Surrendered on reissue Jun 10, 2025 · High confidence
20-year base term ends Oct 18, 2027
Surrendered on reissue Jun 10, 2025 · its term and maintenance fees continue in US RE50,453.
Filed Oct 18, 2007 as application 11/975,297 · Granted Jan 12, 2010
Base term, 20 years from filing, plus 22 days of patent term adjustment (USPTO delay)
Today
Surrendered Jun 10, 2025
2007
2027
Clock starts
Oct 18, 2007
Oct 18, 2007
No longer in force
Jun 10, 2025
Jun 10, 2025
Granted
Jan 12, 2010
Jan 12, 2010
Term would have run to
Nov 9, 2027
Nov 9, 2027
base term
patent term adjustment
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
22
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Fees paid on this patent before its reissue. Those after fall due on the reissue, which carries the term on.
23
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 22 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 18, 2007, when this application, 11/975,297, was filed | Oct 18, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +22 days, USPTO patent term adjustment record | Nov 9, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | no change | High confidence |
| Reissue | US RE50,453 issued Jun 10, 2025, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered Jun 10, 2025 | High confidence |
| Surrendered on reissue | The steps above, in order | Jun 10, 2025 | High confidence |
This family
| US 7,776,905 | In force Jun 2027 | Jun 2027 |
| US 7,645,789 | this patent Jun 2025 | Jun 2025 |
| US 8,415,387 | In force Nov 2027 | Nov 2027 |
| US 8,623,905 | In force Aug 2027 | Aug 2027 |
| US 8,598,181 | In force Aug 2027 | Aug 2027 |
| US 8,575,209 | In force Aug 2027 | Aug 2027 |
| US 8,952,049 | In force Apr 2027 | Apr 2027 |
| US 8,952,050 | In force Apr 2027 | Apr 2027 |
8 of 23 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 8, 2012 Reel 28171, frame 604 | Hadida Ruah, Sara S.; Grootenhuis, Peter D.j.; Van Goor, Fredrick; Zhou, Jinglan; Bear, Brian; Miller, Mark T.; McCartney, Jason; Numa, Mehdi Michel Jamel | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Feb 11, 2016 Reel 37781, frame 332 | Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | Assignee Change of Address |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Mar 21, 2018 Reel 45305, frame 447 | Hadida Ruah, Sara S.; Grootenhuis, Peter D.j.; Van Goor, Fredrick; Zhou, Jinglan; Bear, Brian; Miller, Mark T.; McCartney, Jason; Numa, Mehdi Michel Djamel | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Dec 19, 2022 Reel 62169, frame 886 | Yang, Xiaoqing | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 22 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
154
later US patents cite this one
That is top 5% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.